MedPath

Metoclopramide, versus it’s combination with dexamethasone in the prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy: a double-blind randomized controlled trial

Phase 4
Completed
Conditions
GallstonesGallbladder polyp
Metoclopramide
Dexamethasone
Postoperative nausea and vomiting (PONV)
Laparoscopic cholecystectomy
Registration Number
TCTR20140128001
Lead Sponsor
Royal College of Surgeons of Thailand
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
100
Inclusion Criteria

1. Patients with American Society of Anaesthesiologists physical status classification (ASA) 1-2.
2. Patients requiring elective laparoscopic cholecystectomy.

Exclusion Criteria

1. Pregnancy
2. Breast feeding
3. History of motion sickness
4. Nausea/vomiting use of antiemetics within 24 hrs prior to surgery
5. Insulin-dependent DM
6. Allergy to any protocol medication
7. Conversion to open cholecystectomy
8. Development of intraoperative complication
9. Contraindication for dexamethasone: tuberculosis, herpes simplex virus of ophthalmic
10. Contraindication for metoclopramide: epilepsy, pheochromocytoma, antipsychotic (haloperidol, chlorpromazine) treated patients

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Postoperative nausea and vomiting Postoperative period after laparoscopic cholecystectomy Incidence
Secondary Outcome Measures
NameTimeMethod
Postoperative pain Postoperative period after laparoscopic cholecystectomy Pain score
© Copyright 2025. All Rights Reserved by MedPath